To better understand the mechanisms by which zinc deficiency induces epithelial cell death, studies were done of the effects of intracellular zinc depletion induced by the zinc chelator TPEN on apoptosis-related events in human malignant epithelial cell lines LIM1215 (colonic), NCI-H292 (bronchial), and A549 (alveolar type II). In TPEN-treated cells, depletion of zinc was followed by activation of caspase-3 (as demonstrated by enzymatic assay and Western blotting), DNA fragmentation, and morphologic changes. Increase in caspase-3 activity began 1-2 h after addition of TPEN, suggesting that zinc may suppress a step just before the activation of this caspase. Caspase-6, a mediator of caspase-3 processing, also increased, but later than caspase-3. Effects of TPEN on apoptosis were completely prevented by exogenous ZnSO 4 and partially prevented by peptide caspase inhibitors. A critical substrate of caspase-3 may be the cell cycle regulator p21 Waf1/Cip1 , which was rapidly cleaved in TPEN-treated cells to a 15-kDa fragment before further degradation.
to regulate the pathways of apoptosis in cells. Among the major proapoptotic proteins is the caspase family of aspartate-specific proteases [8] . The caspase family of effector enzymes has been implicated in many [8] , although not all [9] , biochemical pathways leading to apoptosis. Among the caspase-dependent forms of apoptosis, three major pathways have been described [10, 11] . The first involves membrane receptor-ligand interactions (e.g., Fas-FasL binding) and results in activation of the upstream caspase, caspase-8; the second pathway, often triggered by chemical stimuli, causes changes in mitochondrial membrane permeability, release of cytochrome c into the cytoplasm, and subsequent activation of the upstream caspase, caspase-9; a third pathway involves caspase-12 and is triggered in response to stress-induced changes in the endoplasmic reticulum [11] .
Both caspase-8 and caspase-9 trigger, indirectly or directly, activation of the major effector caspase, caspase-3/DEVD-caspase. This caspase-3 in turn cleaves after DXXD in poly (ADPribose) polymerase and other substrates, triggering the distinctive biochemical and morphologic changes associated with this apoptotic cell death [8] . Hence, the detection of this enzyme is critical and has led to the development of an enzymatic assay, based on liberation of a fluorogenic coumarin derivative AFC from the substrate DEVD-AFC [12] . Caspase-3 is activated by cleavage of a 32-kDa zymogen (CPP32); cleavage results in the formation of large and small subunits that rearrange to form an active caspase [12] . Cleavage of the precursor form of caspase-3 is mediated by other caspases, especially caspase-9 and caspase-6 (previously known as Mch2a [13] ). Caspase-9-dependent cleavage of CPP32 is triggered by the release of cytochrome c from mitochondria and is suppressed by Bcl-2 [10, 14] . The factors regulating caspase-6 cleavage of CPP32 are unknown. Therefore the biochemical pathways governing the activation and processing of these caspases are a subject of much interest.
Our laboratory [15] and others [16] [17] [18] recently identified one of these targets as the universal cell cycle regulator p21
Waf1/Cip1 . p21 is an inhibitor of various members of the cyclin-dependent kinases (CDKs), which control the orderly progression of cells through different cell cycle states [19] . p21 contains a domain near its amino terminus that binds to cyclin/CDK complexes; this interaction inhibits CDK activity and hinders its ability to phosphorylate the retinoblastoma family of proteins. This, in turn, is responsible for G 1 /S phase arrest induced by p53 in response to DNA damage [19] . In addition to its N-terminal CDK inhibitory domain, p21 contains a proliferating cell nuclear antigen (PCNA) binding motif located in the carboxy terminal part of the protein that may be important for the inhibition of DNA replication by p21 [20] . Recently, the cleavage of p21 by a caspase-3-like activity during apoptosis in response to various stimuli was reported. These include cleavage of p21 in butyrate-treated LIM1215 cells [15] , tumor necrosis factor-induced apoptosis of human cervical carcinoma cells [16] , and growth factor-deprived human endothelial cells [16] in response to DNA damage by g-irradiation and DNAdamaging agents [18] .
Here we sought to determine whether depletion of intracellular zinc in various epithelial cell lines would influence activation of caspase-3 and caspase-6 and the cleavage of p21. We used three human malignant epithelial cell lines: colonic epithelial LIM1215 cells, bronchial epithelial NCI-H292 cells, and alveolar type II epithelial A549 cells. These cell lines have been widely used in our laboratory to dissect the biochemical pathways regulating apoptosis induced by various agents [21] . Intracellular zinc was depleted by use of the membrane-permeable zinc chelator TPEN [22] , and levels of this zinc were monitored with a UV-excitable intracellular zinc (II)-specific fluorophore, Zinquin [21, 22] .
Methods and Materials
Materials. Major materials and their suppliers were: EDTA, EGTA, herring sperm DNA, Nonidet P-40 (NP-40), dithiothreitol (DTT), sucrose, HEPES (Sigma Chemical, St. Louis); complete protease inhibitor cocktail (Boehringer Mannheim, Mannheim, Germany); penicillin/streptomycin, EDTA/trypsin, RPMI 1640 culture medium, glutamine, CHAPS (ICN, Aurora, OH); gentamicin (David Bull Laboratories, Melbourne); Coomassie brilliant blue G-250 (BDH, Sydney); fetal bovine serum (FBS; Biosciences, Sydney); zDEVD-AFC, zVAD-fmk, zDEVD-fmk (Kamiya Biomedical, Tukwila, WA); VEID-AFC (Calbiochem NSW, Alexandria, Australia); Zinquin, ethyl-[2-methyl-8-p-toluenesulphonamido-6-quinolyloxy]acetate [23] was obtained from A. D. Ward, Department of Chemistry, University of Adelaide, South Australia), dissolved in DMSO as a 5 mM stock solution and stored in aliquots at Ϫ20ЊC in the dark. All other reagents were reagent grade, unless indicated.
Cell cultures. LIM1215 cells were obtained from R. Whitehead (Ludwig Institute, Melbourne), while A549 and NCI-H292 cells were obtained from D. Knight (QEII Medical Centre, Perth, Western Australia). Cell lines were cultured in RPMI 1640, buffered in HEPES at pH 7.4, and supplemented with glutamine (2 mM), penicillin (100 IU/mL), streptomycin (100 mg/mL), gentamicin (160 mg/mL), and 10% FBS in a humidified atmosphere containing 5% CO 2 . Experiments were performed either in 25-cm 2 vented tissue culture flasks or 6-well plates (Sarstedt, Newton, NC). Cells were allowed to attach and grow for 2-3 days to confluence prior to exposure to test reagents. TPEN was added from a stock solution of 5 mM in DMSO to give the final indicated concentration. The final concentration of DMSO was р0.5% after addition of TPEN.
Quantification of Zinquin fluorescence by image analysis. Cells were grown to semiconfluence on sterile glass coverslips in 6-well plates for 48 h before the addition of Zinquin. Coverslips were then washed in PBS and incubated with 25 mM Zinquin in PBS for 30 min at 37ЊC. Coverslips were inverted on microscope slides. Fluorescence was examined by a microscope (BH2; Olympus, Tokyo) equipped with epifluorescence, UV B dichroic mirror for low wavelength excitation, and connected to a Panasonic CCTV video color camera suitable for low light fluorescence with integration capabilities and a computer work station. Both fluorescence images and corresponding phase contrast microscope images were captured and stored using a 20ϫ objective lens. With the VideoPro (Leading Edge) image analysis system, lines were drawn around the borders of cells, and fluorescence intensity within the borders was measured. For all images, background illumination in an area not occupied by cells was subtracted from the readings.
Apoptotic DNA fragmentation. To assay DNA fragmentation, cells ( -10 7 in total) were lysed at 4ЊC in 1 mL of NP-40 6 5 ϫ 10 lysis buffer (5 mM Tris-HCl, pH 7.5, containing 5 mM EDTA and 0.5% NP-40) and centrifuged at 13,000 g for 10 min at 4ЊC. Supernatant fractions containing low-molecular-weight DNA fragments were assayed for DNA by a fluorometric technique [24] . Hoechst dye 33258 was dissolved in deionized water to a concentration of 1 mg/mL and stored at 4ЊC. Prior to use, 1 mL of dye was added per 10 mL of buffer (10 mM Tris-HCl, pH 7.4, containing 1 mM EDTA and 100 mM NaCl). Aliquots of lysate (20-50 mL) were placed into fluorimeter-grade disposable cuvettes (Greiner, Kremsmunster, Austria) and 1 mL of diluted dye solution was added. Fluorescence was measured at an excitation wavelength of 356 nm and emission wavelength of 458 nm (slit widths, 10 nm) in a fluorescence spectrophotometer (LS50; Perkin-Elmer, Norwalk, CT). Herring sperm DNA was used to derive a standard curve.
Measurement of DEVD-caspase (caspase-3) and VEID-caspase (caspase-6) activities. DEVD-caspase was assayed by cleavage of DEVD-AFC (asp-glu-val-asp-7-amino-4-trifluoro-methyl-coumarin), a fluorogenic substrate based on the peptide sequence at the caspase-3 cleavage site of poly (ADP-ribose) polymerase [12] . VEID-caspase was assayed by cleavage of VEID-AFC (val-glu-ileasp-7-amino-4-trifluoro-methyl-coumarin), a fluorogenic substrate based on the peptide sequence at the caspase-6 cleavage site of lamin [13] . Cells ( mL of NP-40 lysis buffer (as for DNA fragmentation). After 15 min in lysis buffer at 4ЊC, insoluble material was pelleted at 15,000 g and an aliquot of the lysate was tested for protease activity. To each assay tube, we added 10-20 mL of cell lysate and then 1 mL of protease buffer (50 mM Hepes, 10% sucrose, 10 mM DTT, 0.1% CHAPS, pH 7.4) containing 8 mM of substrate. After 4-18 h at room temperature, fluorescence was quantified (excitation 400, emission 505) in the LS50 spectrofluorometer. Optimal amounts of added lysate and duration of assay were taken from linear portions of curves as determined in preliminary experiments. One unit of caspase activity was considered to be 1 fluorescence U (at slit widths of 5 nm) per microgram of lysate protein.
Flow cytometric assay for apoptosis. Cells were removed from culture dishes by trypsinization, collected by centrifugation, resuspended in ice-cold PBS, and fixed in absolute methanol for у30 min. Cells were then washed in PBS containing 0.5% Tween 20, followed by two washes in PBS containing 2% fetal calf serum (FCS). After the washes, cells were resuspended in PBS/2% FCS containing 40 mg/mL RNase A and incubated for 20 min at 37ЊC. Finally, cells were washed in PBS/2% FCS and resuspended in PBS containing propidium iodide (20 mg/mL). The stained nuclei were analyzed by flow cytometer (Epics Profile; Coulter, Hialeah, FL). Cell cycle distribution was based on 2N and 4N DNA content. Cells with !2N DNA content were indicative of apoptotic cells. A linear measurement scale was used for quantification.
Morphologic assessment of apoptosis. Apoptosis was also assessed in some experiments by chromatin condensation in hematoxylin eosin (HE)-stained cell cultured coverslips and by labeling of nuclear fragments with Hoechst dye 33258 (1 mg/mL). One thousand cells were scored from replicate tubes.
Protein assay. Protein concentration was measured by the DC protein assay kit (BioRad Laboratories, Hercules, CA) in accordance with the manufacturer's instructions.
Western blotting. Cell aliquots were lysed in NP-40 lysis buffer (5 mM Tris-HCl, pH 7.5, containing 5 mM EDTA, 0.5% NP-40, and complete protease inhibitor cocktail) and stored at Ϫ20ЊC until assayed. (18-36 mg) were loaded into wells and electrophoresed on 12% minigels (Bio-Rad) at 200 V for 45 min. To ensure that equal amounts of protein were loaded in each track, duplicate gels were also stained with Coomassie brilliant blue G-250. Proteins were blotted onto Immobilon-P polyvinylidene difluoride membrane (Millipore, Sydney). Membranes were preblocked with 3% powdered milk in Tris-buffered saline/0.1% Tween 20 and 3% bovine serum albumin for 60 min at room temperature.
Primary antibodies used were mouse monoclonal anti-human p21 (clone 6B6, 1/333 dilution; PharMingen, San Diego), goat polyclonal anti-human Mch2 p20 (K-20) IgG (1/500 dilution, Santa Cruz Biotech, Santa Cruz, CA) and goat polyclonal anti-human CPP32 p20 (N-19) IgG (1/1000 dilution, Santa Cruz Biotech). Secondary antibody was either sheep anti-mouse IgG peroxidase conjugate (1/1000 dilution, Fab fragment; Boehringer Mannheim) or anti-goat IgG peroxidase conjugate (1/1000 dilution, whole antibody, Santa Cruz Biotech). Primary antibodies were added for 60 min and secondary antibodies for 45 min at room temperature.
Membranes were then soaked in enhanced chemiluminescence Western blotting reagent (Amersham Life Sciences, Sydney), and bands were detected by chemiluminescence. Rainbow high-molecular-weight markers (Amersham Life Sciences) were used for determination of molecular weight.
Experimental design. All experiments were repeated a minimum of three times. Statistical significance was determined by Student's t test and as indicated in text or figure legends.
Results

Intracellular zinc depletion by TPEN as demonstrated by decrease in Zinquin fluorescence.
In order to deplete intracellular zinc, cell lines were treated with varying concentrations of the membrane-permeable zinc chelator TPEN. Intracellular zinc content (specifically the more labile pools of zinc) were monitored by loading the cells with the zinc-specific fluorophore Zinquin. Figure 1 shows the strong quenching of Zinquin fluorescence by TPEN in two of these cell lines, A549 (upper panels) and NCI-H292 (lower panels). The panel on the right in figure 1 represents the normal zinc content of the cells, while the panels on the left show the zinc-depleted cells after addition of TPEN for 1 h. Zinquin fluorescence was significantly quenched by TPEN, which has a much higher affinity for zinc than Zinquin [22] . Thus, in NCI-H292 cells, specific mean fluorescence intensity decreased from pixels ( ) 23.1 ‫ע‬ 2.2 n p 29 To determine the effects of zinc depletion on caspase-3 activation, epithelial cells were treated with varying concentrations of TPEN for 4 h. Cell lysates were prepared and assayed for DEVD-caspase activity ( figure 2A) . In each of the three cell lines, there was a significant increase in DEVD-caspase activity, especially at TPEN concentrations у12.5 mM. Thus, in LIM1215 cells ( figure 2A,) , there was a small but significant ( ) increase in DEVD-caspase activity with P р .05 6.25 mM TPEN, followed by highly significant increases (P р ) at 12.5 and 25 mM TPEN (the latter yielding a maximal .005 response).
The kinetics of these increases were studied using 25 mM TPEN. DEVD-caspase activity increased slowly between 1 and 2 h after addition of TPEN in both cell lines studied (NCI-H292 and LIM1215, figure 2B) . After 2 h, there were sharp rises in DEVD-caspase activity, increasing linearly up to 6 h (the latest time point tested). The induction of DEVD-caspase activity by TPEN was prevented at all time points when cells also received exogenous ZnSO 4 (25 mM). Thus, after 5 h of TPEN treatment in LIM1215 cells ( figure 2B,) , there was an increase in DEVD-caspase activity over the control (no TPEN) of 5.9 U/mg of protein. Similarly, for NCI-H292 cells ( figure  2B,) , there was a corresponding increase of 5.4 U/mg of protein. When LIM1215 cells were treated with TPEN in the presence of 25 mM of ZnSO 4 , there was a 10-fold reduction to 0.4 U/mg of protein. Since TPEN can also chelate copper and nickel, it is possible that some of the responses were due to chelation of these metal ions. However, our zinc supplementation studies demonstrated that TPEN was acting by chelating zinc.
The fluorogenic substrate assays, which showed an increase in DEVD-caspase activity in TPEN-treated cells, could indicate rises in caspase-3 or caspase-7, both of which can cleave this substrate. The Western blot in figure 3 confirmed that TPEN induced caspase-3 activity, as determined by the decrease in the 32-kDa zymogen form (CPP32) of caspase-3. The antibody used in this blot failed to pick up either of the active subunits of caspase-3, probably due to the specificity of the antibody used. The decrease in CPP32 was most evident between 2 and 3 h after addition of TPEN (figure 3A), consistent with the results of the fluorogenic substrate assay (figure 2B).
Zinc depletion by TPEN induces caspase-6 activation. CPP32 can be processed to its active form by other caspases, including caspase-6. To determine whether TPEN is activating caspase-3 by inducing caspase-6, LIM1215 or NCI-H292 cells were treated with 25 mM TPEN for varying periods. Caspase-6 activity was monitored by Western blotting to detect the active p20 subunit (figure 3B) or by a fluorogenic substrate assay with VEID-AFC. The active p20 subunit of caspase-6 did not increase significantly in the first 2 h after addition of TPEN to LIM1215 cells but increased steadily after 2 h (figure 3B). Similar results were obtained by the enzymatic assay, with increases in VEID-caspase occurring after 2 h in LIM1215 cells and after 3 h in NCI-H292 cells (figure 4). These observations suggest that caspase-6 is not significantly involved in the activation of caspase-3 in zinc-depleted epithelial cells.
Zinc depletion induces DNA fragmentation and apoptosis. Effects on apoptosis were determined by measuring DNA fragmentation and by flow cytometry. Data are shown for LIM1215 cells. DNA fragmentation induced by TPEN displayed a similar dependence on concentration (figure 5A) and time (figure 5B) to that of DEVD-caspase activation. The first increase in DNA fragmentation occurred after 2 h and a large increase occurred after 3 h and was almost linear up to 6 h. Flow cytometry analysis with propidium iodide showed a progressive increase in apoptotic cells, as indicated by appearance of an increasing fraction of cells with less than 2N DNA content, preceding the G 1 peak on the fluorescence scans (figure 6). Cells containing hypodiploid DNA increased 1 h after addition of TPEN and plateaued at 3 h. The discordance between DNA fragmentation (figure 5B) and flow cytometry (figure 6) for apoptosis may be due to the presence of necrotic cells and differences between processing techniques for the two assays. When observed microscopically, cells treated with TPEN had chromatin condensation (as determined by HE staining), nuclear fragmentation (as determined by Hoechst dye 33258), and formation of distinct apoptotic bodies consistent with apoptosis (not shown).
Caspase inhibitors block TPEN-induced caspase-3 activation but only partially block DNA fragmentation. To determine whether caspases are involved in the subsequent apoptosis of TPEN-treated epithelial cells, two specific membrane-permeable peptide inhibitors of caspase-3 were used. zDEVD-fmk is a specific inhibitor of caspase-3, while zVAD-fmk is an inhibitor of a broad spectrum of caspases [10] . Both inhibitors completely inhibited DEVD-caspase activity in TPEN-treated LIM1215 cells (figure 7A), although it was not determined whether the peptide inhibitors blocked the active caspase-3 or the caspasedependent steps leading to activation of caspase-3. Despite the complete inhibition of DEVD-caspase activity, there was only partial inhibition of DNA fragmentation, even at higher concentrations of inhibitors (figure 7B). Hence DNA fragmentation in zinc-depleted cells was partially caspase independent. Although the level of DNA fragmentation in cells treated with zVAD-fmk appeared to be higher than in control cells, there was no statistically significant increase ( ). P 1 .05 TPEN induces loss of p21 associated with appearance of p15 and eventually loss of both species. Previous studies from our laboratory and others identified the cell cycle regulator p21 as a specific substrate of caspase-3 in cells induced to apoptose by butyrate and other agents [15] [16] [17] [18] . We therefore determined whether p21 was also cleaved in zinc-depleted cells. LIM1215 cells were treated with 25 mM TPEN for varying time periods, and lysates were assayed by Western blotting with a p21 monoclonal antibody. This antibody also detected the larger p15 cleavage product of p21 formed by caspase-3-dependent cleavage of p21 at D 112 . Decrease in p21 and appearance of p15 first occurred 1 h after addition of TPEN ( figure 8, track B) . By 2 h, most of the p21 had been cleaved, and there was a major band corresponding to p15. By 4 h, neither p21 nor p15 were detectable, suggesting further degradation of p15. Similar results were obtained for the other cell line tested (A549) (data not shown).
Effects on p21 are mediated, at least in part, by caspase-3 cleavage. A comparison of the time courses of caspase-3 activation and p21 degradation in TPEN-treated cells suggests that p21 loss is mediated by caspase-3. To investigate this further, LIM1215 cells were pretreated with zDEVD-fmk (0-100 mM) for 1 h before the addition of 25 mM TPEN for a further 2 h. Lysates were then prepared and assayed by Western blotting with p21. At 50 and 100 mM zDEVD-fmk, there was complete suppression of cleavage of p21 to p15 (data not shown).
Discussion
Enhanced apoptotic cell death in epithelial tissues is a consequence of in vivo zinc deficiency and may play an important role in the formation of the characteristic vesicular skin lesions [25] , damage to the gastrointestinal lining and associated diarrhea [26] , and sloughing of the respiratory epithelium. This study addressed the mechanisms by which depletion of intracellular zinc induces apoptosis of epithelial cells by use of an in vitro model in which human malignant epithelial cell lines were treated with the zinc chelator TPEN. This study had three major conclusions: Apoptosis in zinc-depleted cells proceeds via a caspase-3-dependent process, there is only a short lag period (1-2 h) between addition of TPEN and onset of caspase-3 activation, and activation of caspase-3 is rapidly followed by loss of p21
Waf1/Cip1 , first to a 15-kDa fragment and then further degraded.
Our findings in TPEN-treated cells of (first) an increase in DEVD-caspase activity, (second) loss of the 32-kDa zymogen form of caspase-3, and (third) partial suppression of DNA frag- mentation by caspase peptide inhibitors (including a specific inhibitor of caspase-3, zDEVD-fmk), argue for a major role of caspase-3 in the TPEN-induced apoptosis. This conclusion is strengthened by the recent study of TPEN-induced cell death in human renal cell carcinoma cell lines, in which mutant cell lines lacking caspase-3 were resistant to TPEN-induced apoptosis [7] . Since these resistant cell lines also had variable decreases in caspase-7, -8, and -10, it cannot be ruled out that loss of one of these upstream caspases may also have been important. Caspase-6, the caspase responsible for cleavage of nuclear lamins [13] , was also activated in zinc-depleted cells in our study, and this caspase may be responsible for the subsequent nuclear fragmentation in zinc-depleted cells. Suppression of TPEN-induced DNA fragmentation by the caspase-3 peptide inhibitor zDEVD-fmk was only partial, despite complete suppression of DEVD-caspase activity. That other caspases may substitute for caspase-3 is unlikely since the broad-spectrum caspase inhibitor zVAD-fmk was also only partially able to suppress DNA fragmentation. We believe that at least some of the resulting DNA fragmentation is via a caspase-independent mechanism, although whether DNA fragmentation also occurs by nonapoptotic mechanisms cannot be ruled out. The observations that TPEN lowers intracellular zinc under the conditions used in this study and that zinc supplementation prevents the effects of TPEN on apoptosis of these cells, suggests that depletion of zinc is responsible for most, if not all, of the actions of TPEN on these cells.
We recently reported on the importance of zinc as a regulator of apoptosis [27] . The mechanism by which intracellular zinc depletion triggers caspase-3 activation remains unclear. In view of the short lag period (1-2 h) between addition of TPEN and onset of caspase-3 activation, zinc must influence a step relatively close to that of caspase-3 activation. Indeed, in primary tracheobronchial ciliated epithelial cells, zinc is concentrated in the apical cytoplasm [28] , the same region in which the precursor form of caspase-3 is localized [29] . Caspase-3 activation involves the proteolytic processing of a 32-kDa zymogen by other caspases; both caspase-9 [14] and caspase-6 [30] have been implicated in this processing. It is of interest that both of these caspases are very sensitive to inhibition by zinc [13, 31, 32] . TPEN might therefore act by stripping zinc from either or both of these caspases, thus enhancing their activity. We were unable to show any significant activation of caspase-6 prior to activation of caspase-3. Caspase-6 was activated in TPEN-treated cells, but only at time points later than that of caspase-3 activation. It is possible that only small amounts of caspase-6 are required for processing of caspase-3 and that these levels were too low to be detected by our fluorogenic substrate assay. Effects of zinc depletion on caspase-9 activity now need to be determined. Alternatively, zinc may influence the levels of auxiliary factors in the activation of caspase-3. Candidates include members of the Bcl-2 family of proteins, which suppress caspase-3 activation and may be up-regulated by zinc supplementation [33] . Another candidate may be nitric oxide, since a nitric oxide synthase inhibitor protects mice from zinc deficiency-induced apoptosis and damage in the gastrointestinal epithelium [34] .
The third major conclusion of this study is that activation of caspase-3 in zinc-depleted cells is rapidly followed by loss of the cell-cycle regulator p21 Waf1/Cip1 . This loss occurs in two steps: Initially, there is cleavage of p21 to a 15-kDa derivative, which we [14] and others [15] [16] [17] have shown to arise by caspase-3-dependent cleavage of p21 at D 112 . This cleavage, which separates the N-terminal domain (that binds to and inhibits the cyclin-cdk complex) from the C-terminal (that binds to the nuclear proliferation-associated marker PCNA), results in a 15-kDa fragment that cannot localize in the nucleus but facilitates apoptosis by poorly understood mechanisms. After the initial cleavage of p21, there was complete loss in zinc-depleted cells. Since the turnover of p21 is regulated by the proteasome complex of proteases [35] , the initial cleavage to p15 may expose sites that facilitate ubiquitinization and subsequent targeting to the proteasome. Loss of p21 may result in premature entry of the cells into S-phase, and apoptotic cell death occurs in some other forms of apoptosis [36] . Experiments to test the effect of zinc depletion on apoptosis in cells transfected with a mutant form of p21 that has an alanine instead of aspartate at position 112 and which will, therefore, be resistant to caspase-dependent cleavage, should prove informative.
The extent to which in vivo zinc deficiency is associated with enhanced rates of caspase activation, p21 degradation, and apoptosis in epithelial tissues needs to be determined. This will best be answered in the context of experimental zinc deficiency in animals that will allow these parameters to be correlated with impaired barrier function and increased rates of infections.
